series-c-plus
Stage
1
Investors
About
ORIC Pharmaceuticals is a clinical-stage oncology company developing small molecule therapies to overcome resistance mechanisms in cancer treatments, focusing on improving the efficacy of existing therapies and addressing treatment-resistant cancers.
Explore ORIC Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.